BCG immunotherapy – from pathophysiology to clinical practice

Bibliography

• JACOBSON DL, GANGE SJ, ROSE NR, GRAHAM NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. (1997) 84:223-243.
   PubMedGoogle Scholar
• SHOENFELD Y: Common infections, idiotypic dysregulation, autoantibody spread and induction of autoimmune diseases. J. Autoimmunity (1996) 9:235-239.
   PubMed Web of Science ®Google Scholar
• COHEN AD, SHOENFELD Y: Vaccine –induced autoimmunity. J. Autommunity (1996) 9:699-703.
   PubMed Web of Science ®Google Scholar
• ASHERSON R, SHOENFELD Y: The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome-molecular mimicry? J. Rheumatol. (2000) 27:12-14.
   PubMed Web of Science ®Google Scholar
• SHOENFELD Y, AHARON-MAOR A, SHERER Y: Vaccination as an additional player in the mosaic of autoimmunity. Clin. Exp. Rheumatol. (2000) 18:1-4.
   PubMed Web of Science ®Google Scholar
• WRAITH DC, GOLDMAN M, LAMBERT PH: Vaccination and autoimmune disease: what is the evidence? Lancet (2003) 362: 1659-1666.
   PubMed Web of Science ®Google Scholar
• TISHLER M, SHOENFELD Y: Vaccination may be associated with autoimmune diseases. Isr. Med. Assoc. J. (2004) 6:430-432.
   PubMed Web of Science ®Google Scholar
• BACH JF: The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. (2002) 347:911-920.
   PubMed Web of Science ®Google Scholar
• WUCHERPFENNIG KW: Mechanisms for the induction of autoimmunity by infectious agents. J. Clin. Invest. (2001) 108:1097-1104.
   PubMed Web of Science ®Google Scholar
• THEOPHILOPOULOS AN, DUMMER W, KONO DW: T cell homeostasis and systemic autoimmunity. J. Clin. Invest. (2001) 108:335-340.
   PubMed Web of Science ®Google Scholar
• TEPLIZKI H, BUSKILA D, ALKAN M, COATES A, BAUMGARTEN A, SHOENFELD Y: ELISA measurement of antibody titer to purified protein derivative and mycobacteria derived phosphoglycolipids: tools for diagnosing active pulmonary tuberculosis. Isr. J. Med. Sci. (1987) 23:1121-1124.
   PubMedGoogle Scholar
• LINDQVIST KH, COLEMAN RE, OSTERLAND CK: Autoantibodies in chronic pulmonary tuberculosis. J. Chron. Dis. (1997) 22:717-725.
   Google Scholar
• SHOENFELD Y, VOLMAR Y, COATES ARM, RAUCH J, SHAUL D, PINHAS J: Monoclonal antituberculosis antibodies react with DNA, and monoclonal antiDNA and autoantibodies react with Mycobacterium tuberculosis. Clin. Exp. Immunol. (1986) 66:255-261.
   PubMed Web of Science ®Google Scholar
• THOMAS CJ, MORRIS JA: Common epitopes between mycobacteria and certain host tissue antigens. Clin. Exp. Immunol. (1985) 61:323-328.
   PubMed Web of Science ®Google Scholar
• GLYNN P, WEEDA D, EDWARDS J, SUCHLINY AJ, CUZNER ML: Humoral immunity in chronic relapsing experimental encephalomyelitis. The major oligoclonal IgG bands are antibodies to mycobacteria. Neurol. Sci. (1982) 57:369-364.
   Web of Science ®Google Scholar
• HOLOSHITZ J, MATITIAHU A, COHEN IR: Arthritis induced in rata by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J. Clin. Invest. (1984) 73:211-215.
   PubMed Web of Science ®Google Scholar
• VAN EDEN W, HOLOSHITZ J, NEVO Z, FRENKEL A, KLUJMAN A, COHEN IR: Arthritis induced by a T lymphocyte clone that responds to M. tuberculosis and to cartilage proteoglycans. Proc. Natl. Acad. Sci. USA (1985) 82:5113-5120.
   Google Scholar
• HOLOSHITZ J, KLUJMAN A, DRUCKER I et al.: T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria crossreactive with cartilage. Lancet (1986) 2:305-309.
   PubMed Web of Science ®Google Scholar
• BAXTER AG, HORSFALL AC, HEALY D et al.: Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology (1994) 83:235-248.
   Google Scholar
• HORSFALL AC, HOWSON R, SILVEIRA RA, WILLIAMS DG, BAXTER G: Characterization and specificity of B cell responses in lupus induced by M. bovis in NOD/Lt. mice. Immunology (1998) 95:8.
   PubMed Web of Science ®Google Scholar
• KURTH KR, BOUFFLOUX C, SYLVESTER R, VAN DER MEIJDEN AP, OOSTERLINK W, BRAUSE M: Treatment of superficial bladder tumours: achievements and needs. The EORTC Genitourinary Group. Eur. Urol. (2002) 27(Suppl. 3):1-9.
   Google Scholar
• LAMM DL, VAN DER MEIJDEN AP, MORALES A et al.: Incidence and treatment of BCG intravesical therapy in superficial bladder cancer. J. Urol. (1992) 147:598-600.
   Google Scholar
• MAS AJ, ROMERA M, VALVERDE GARCIA JM: Articular manifestations after the administration of intravesical BCG. Joint Bone Spine (2002) 69:92-93.
   PubMed Web of Science ®Google Scholar
• SHOENFELD Y, ARON-MAOR A, TANAI A, EHRENFELD M: BCG and autoimmunity. Another two-edged sword. J. Autoimmun. (2001) 16:235-240.
   PubMed Web of Science ®Google Scholar
• MOULY S, BERENBAUM F, KAPLAN G: Remitting seronegative synovitis with pitting edema following intravesical BCG instillation. J. Rheumatol. (2001) 28:1699-1701.
   PubMed Web of Science ®Google Scholar
• PARDALIDIS NP, PAPATSORIS AG, KOSMAOGLOU EV, GEORGANAS C: Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer. Clin. Rheumatol. (2002) 21:536-537.
   PubMed Web of Science ®Google Scholar
• CLAVEL G, GRADOS F, CAYROLLE G et al.: Polyarthritis following intravesical BCG immunotherapy. Report of a case and a review of 20 cases in the literature. Rev. Rhum. Engl. Ed. (1999) 66:115-118.
   PubMedGoogle Scholar
• TINAZZI E, FICARRA V, SIMEIONI S, PETERLANA D, LUNARDI C: Reactive arthtritis following BCG immunohterapy for bladder carcinoma. Clin. Rheumatol. (2005) 24:425-427.
   PubMed Web of Science ®Google Scholar
• KASS E, STRAUME S, MUNTHE E: Dermatomyositis after BCG vaccination. Lancet (1978) 1(8072):772.
   PubMedGoogle Scholar
• EHRENGUT W: Dermatomyositis and vaccination. Lancet (1978) 1(8072):1040-1041.
   PubMedGoogle Scholar
• KASS E, STRAUME S, MELLBYE OJ, MUNTHE E, SALHEIM BG: Dermatomyositis associated with BCG vaccination. Scand. J. Rheum. (1979) 8:187-191.
   PubMed Web of Science ®Google Scholar
• BARTOLOME PACHECO MJ, MARTINEZ-TABOADA VM, BLANCO R, RODRIGUEZ-VALVERDE V, VALLE JI, LOPEZ-HOYOS M: Reactive arthritis after BCG immunotherapy: T-cell analysis in peripheral blood and synovial fluid. Rheumatology (2002) 41:1119-1125.
   PubMed Web of Science ®Google Scholar
• PRESCOTT S, JACKSON AM, HAWKYARD SJ, ALEXANDROFF AB, JAMES K: Mechanisms of action of intravesical BCG: local immune mechanisms. Clin. Infect. Dis. (2000) 31:591-593.
   Google Scholar
• JACKSON AM, ALEXANDROFF AB, KELLY RW et al.: Changes in urinary cytokines and soluble intracellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after BCG immunotherapy. Clin. Exp. Immunol. (1995) 99:369-375.
   PubMed Web of Science ®Google Scholar
• PRESCOTT S, JAMES K, BUSUTTIL A, HARGREAVE TB, CHISHOLM GD, SMYTH JF: HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br. J. Urol. (1989) 63:264-269.
   PubMedGoogle Scholar
• HOLOSHITZ, NAPARSTEK Y, BEN NUN A, COHEN IR: Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science (1983) 219:56-58.
   PubMed Web of Science ®Google Scholar
• ABRAHAMSON G, FROLAND SS, MATVIG JB: In vitro mitogen stimulation of synovial fluid lymphocytes from rheumatoid arthritis and juvenile rheumatoid arthritis patients: dissociation between the response to antigens and polyclonal mitogens. Scand. J. Immunol. (1978) 7:81-90.
   PubMed Web of Science ®Google Scholar
• ARON-MAOR A, SHOENFELD Y: BCG immunization and the ‘Trojan Horse’ phenomenon. Clin. Rheum. (2003) 22:6-7.
   PubMed Web of Science ®Google Scholar